methylprednisolone hemisuccinate

Preferred Label : methylprednisolone hemisuccinate;

MeSH definition : A water-soluble ester of METHYLPREDNISOLONE used for cardiac, allergic, and hypoxic emergencies.;

MeSH synonym : hemisuccinate, methylprednisolone; methylprednisolone succinate; succinate, methylprednisolone;

CISMeF synonym : 11.beta.,17,21-trihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione 21-(hydrogen succinate); 2375-03-3 (Methylprednisolone hemisuccinate monosodium salt);

MeSH hyponym : A-MethaPred; methylprednisolone sodium succinate; Urbason-Soluble; Solu-Medrol; UrbasonSoluble; Solumedrol; Sodium Succinate, Methylprednisolone; Methylprednisolone Hemisuccinate Monosodium Salt; 6 alpha-Methylprednisolone Sodium Hemisuccinate; Methylprednisolone Sodium Hemisuccinate; Sodium Hemisuccinate, Methylprednisolone;

MeSH CAS label : Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-;

MeSH Related Number : 2921-57-5 (Methylprednisolone hemisuccinate); methylprednisolone sodium succinate; LEC9GKY20K;

Registry Number MeSH : 2921-57-5;

Related CAS MeSH : LEC9GKY20K (Methylprednisolone sodium succinate);

Codes EINECS : 220-863-9;

Is substance : O;

UNII : 5GMR90S4KN;

InChIKey : IMBXEJJVJRTNOW-XYMSELFBSA-N;

Details

Origin ID

D008776;

UMLS CUI

C0025819;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- 11.beta.,17,21-trihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione 21-(hydrogen succinate) [Substance BNPC]
Currated CISMeF NLP mapping
- Methylprednisolone Hemisuccinate [NCIt concept]
- Methylprednisolone hemisuccinate (substance) [SNOMED CT concept]
- Methylprednisolone hydrogen succinate [SMS substance]
Pharmacological action(s)
- anti-inflammatory agents [MeSH Descriptor]
- antineoplastic agents, hormonal [MeSH Descriptor]
- glucocorticoids [MeSH Descriptor]
- neuroprotective agents [MeSH Descriptor]
Record concept(s)
- A-MethaPred [MeSH concept]
- Solu-Medrol [MeSH concept]
- Urbason-Soluble [MeSH concept]
- methylprednisolone hemisuccinate [MeSH concept]
- methylprednisolone sodium succinate [MeSH concept]
Related MeSH Supplementary Concept(s)
- 6-methylprednisolone-21-hemisuberate N,N,N'-triethylenediamine amide [MeSH Supplementary Concept]
- ASHAP protocol [MeSH Supplementary Concept]
- BOMES protocol [MeSH Supplementary Concept]
- M-BACOS protocol [MeSH Supplementary Concept]
- MINE-ESHAP protocol [MeSH Supplementary Concept]
- VIM3-ARA C regimen [MeSH Supplementary Concept]
- methylprednisolone 17-hemisuccinate [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- 11.beta.,17,21-trihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione 21-(hydrogen succinate) [Substance BNPC]
- Methylprednisolone Hemisuccinate [NCIt concept]
- Methylprednisolone hemisuccinate (substance) [SNOMED CT concept]
Validated automatic mappings to BTNT
- Methylprednisolone sodium succinate (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients